サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：希少神経疾患治療市場：薬剤クラス別、疾患タイプ別、用途別、国別、地域別：産業分析、市場規模、市場シェア、2023-2030年予測
市場調査レポート
商品コード
1320165

希少神経疾患治療市場：薬剤クラス別、疾患タイプ別、用途別、国別、地域別：産業分析、市場規模、市場シェア、2023-2030年予測

Rare Neurological Disease Treatment Market with COVID-19 Impact Analysis, By Drug Class, By Disease Type, By Application, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
出版日: | 発行: AnalystView Market Insights | ページ情報: 英文 356 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.58円
希少神経疾患治療市場：薬剤クラス別、疾患タイプ別、用途別、国別、地域別：産業分析、市場規模、市場シェア、2023-2030年予測
出版日: 2023年07月01日
発行: AnalystView Market Insights
ページ情報: 英文 356 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

レポートハイライト

希少神経疾患治療市場規模は2022年に94億3,530万米ドルとなり、2023年から2030年にかけてCAGR 7.7%で拡大

希少神経疾患治療市場-市場力学：

研究開発活動の活発化が希少神経疾患治療の需要を促進すると予測されます。

研究者、医療専門家、製薬企業、患者支援団体の連携は、珍しい神経疾患の治療薬の創出を促進する上で不可欠です。患者支援団体は、研究を促進し、支援し、認知度を高めることで、患者の転帰や治療選択肢を改善しています。次世代シークエンシング、ハイスループットスクリーニング、遺伝子編集法などの技術の進歩は、珍しい神経疾患に対する実行可能な治療法の探索と開発を加速させています。研究者たちは、これらの技術のおかげで、治療標的を特定し、まったく新しい薬剤を開発し、治療戦略を個別化することができるようになっています。

ゲノミクスと分子生物学の発展により、珍しい神経疾患に関与する生物学的遺伝学的・分子生物学的な進展が、よりよく理解されるようになっています。この情報により、精密医療や標的治療薬に新たな可能性が生まれています。

希少神経疾患治療市場-主な洞察：

  • 当社のリサーチアナリストが共有した分析によると、世界の希少神経疾患治療市場は、予測期間（2023-2030年）に約7.7％のCAGRで毎年成長すると推定されています。
  • 希少神経疾患治療産業は、動物の健康と栄養への注目の高まりにより、著しい速度で成長すると予測されています。
  • 疾患タイプ別では、アルツハイマー病分野が2022年に最大市場シェアを示すと予測されます。
  • 用途別では、病院薬局セグメントが2030年までに大きな市場シェアを占めると予測されます。
  • 薬剤クラス別では、抗うつ薬セグメントが2022年にリードしています。
  • 地域別では、北米が2022年に最大の収益源となりました。

希少神経疾患治療市場-セグメンテーション分析：

世界の希少神経疾患治療市場は、薬剤クラス、疾患タイプ、用途、地域に基づいてセグメント化されます。

市場は薬剤クラスに基づいて5つのカテゴリーに分けられる：抗うつ薬、抗精神病薬、コリンエステラーゼ阻害薬、生物学的製剤、その他。市場を独占しているのは抗うつ薬セグメントです。疾病治療のための抗うつ薬に対する需要の高まりが市場成長に寄与しています。

市場は疾患タイプ別に4つに分類される：アルツハイマー病、ナルコレプシー、硬化症、その他。アルツハイマー病分野が市場を独占しています。アルツハイマー病の有病率の増加が市場成長に影響を与えています。

市場は用途別に3つのカテゴリーに分類される：病院＆クリニック、外科センター、その他。病院薬局セグメントが市場を独占しています。病院レベルでの神経疾患治療件数の増加が、このセグメントの成長を高めています。

希少神経疾患治療市場-地理的洞察：

地理的に、この市場は北米、ラテンアメリカ、欧州、アジア太平洋、中東アフリカの地域に広がっています。これらの地域は、ビジネスをもたらす国によってさらに分けられます。

希少神経疾患治療市場-競合情勢：

神経疾患の有病率が上昇しており、希少神経疾患治療市場に影響を与えています。企業のウェブサイトや製品タイプなど、いくつかの販売チャネルがソリューションや製品を販売するために企業によって使用されています。製品は、技術、製品開発、マーケティングなど様々な要因で競合しています。リーチを固め、市場シェアを拡大するために企業が用いる主な手法や戦略には、新製品の発売、研究開発費、流通網の開拓、M&Aなどがあります。最近の動向の一部を以下に紹介します。

最近の動き

2021年、Biogen は低分子治療薬アンチセンスオリゴヌクレオチドSpinraza（ヌシネルセン）を開発しました。

研究の主な特徴

  • この調査レポートは、希少神経疾患治療市場の市場規模、CAGR 、2022年を基準年とした推定・予測（2023-2030年）を提供しています。
  • この調査レポートは、希少神経疾患治療市場に関する最新の動向洞察を顧客に提供します。
  • 調査レポートは、さまざまなセグメント/国にわたる潜在的な成長機会を解明し、希少神経疾患治療市場の魅力的な投資提案マトリクスを説明します。
  • 全体的なレポートでは、新規投資機会、既存企業が直面する課題、希少神経疾患治療市場で持続するための成長要因を特定している
  • 希少神経疾患治療市場規模、予測、CAGR、市場力学に対するCOVID-19の影響について調査範囲で詳しく論じています。COVID後の希少神経疾患治療市場に関する詳細な洞察もカバーします。
  • 本レポートのユーザーに希少神経疾患治療市場の包括的な見解を提供するために、希少神経疾患治療市場の競合情勢と主要イノベーター分析も含めています。
  • 本調査では、市場規模、成長率、魅力度に基づいてすべての業界セグメントをベンチマークした成長見通しマッピング分析を網羅しています。
  • 本レポートは、希少神経疾患治療市場で事業を展開する企業の薬剤クラスにおける財務状況や戦略的イニシアチブを理解するのに役立つ、主要市場参入企業を特集した詳細な企業プロファイルを提供しています。
  • さらに、本レポートでは、世界レベルだけでなく地域レベルで市場に関与する主要参入企業の重要な買収＆合併、提携＆ジョイントベンチャー、新発売、研究開発、地域展開も明らかにしています。
  • 世界の希少神経疾患治療市場レポートは主に、サプライヤー、投資家、新規参入者、流通業者、金融アナリストなど、この業界の様々な利害関係者を対象としています。

目次

第1章 希少神経疾患治療市場概要

  • 調査範囲

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合考察

第3章 希少神経疾患治療の主要な市場動向

  • 希少神経疾患治療市場促進要因
  • 希少神経疾患治療市場抑制要因
  • 希少神経疾患治療市場の機会
  • 希少神経疾患治療市場の今後の動向

第4章 希少神経疾患治療産業の調査

  • PEST分析
  • ポーターのファイブフォース分析
  • 成長見通しのマッピング
  • 規制枠組みの分析

第5章 希少神経疾患治療市場：COVID-19の影響分析

  • COVID-19以前の影響分析
  • COVID-19後の影響分析

第6章 希少神経疾患治療の市場情勢

  • 希少神経疾患治療市場シェア分析、2022年
  • 主要メーカー別の内訳データ
    • 既存企業の分析
    • 新興企業の分析

第7章 希少神経疾患治療市場- 薬剤クラス別

  • 概要
    • 薬剤クラス別のセグメントシェア分析
    • 抗うつ薬
    • 抗精神病薬
    • コリンエステラーゼ阻害剤
    • 生物製剤
    • その他

第8章 希少神経疾患治療市場- 疾患タイプ別

  • 概要
    • 疾患タイプ別セグメントシェア分析
    • アルツハイマー病
    • ナルコレプシー
    • 硬化症
    • その他

第9章 希少神経疾患治療市場- 用途別

  • 概要
    • 用途別セグメントシェア分析
    • 病院と診療所
    • 外科センター
    • その他

第10章 希少神経疾患治療市場-地域別

  • イントロダクション
  • 北米
    • 概要
    • 北米の希少神経疾患治療の主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州の希少神経疾患治療の主要メーカー
    • ドイツ
    • イタリア
    • 英国
    • フランス
    • ロシア
    • オランダ
    • スウェーデン
    • ポーランド
    • その他
  • アジア太平洋（APAC）
    • 概要
    • アジア太平洋地域の希少神経疾患治療の主要メーカー
    • インド
    • 中国
    • 日本
    • 韓国
    • オーストラリア
    • タイ
    • インドネシア
    • フィリピン
    • その他
  • ラテンアメリカ
    • 概要
    • ラテンアメリカの希少神経疾患治療の主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東とアフリカ
    • 概要
    • 中東およびアフリカの希少神経疾患治療の主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第11章 主要ベンダー分析- 希少神経疾患治療産業

  • 競合ダッシュボード
  • 企業プロファイル
    • Biogen Inc.
    • Genzyme Corporation
    • Novartis International AG
    • Roche Holding AG
    • Pfizer Inc.
    • Johnson &Johnson
    • AbbVie Inc.
    • Merck &Co., Inc.
    • Teva Pharmaceutical Industries Ltd.
    • Takeda Pharmaceutical Company Limited
    • Alexion Pharmaceuticals, Inc.
    • Amgen Inc.
    • Vertex Pharmaceuticals Incorporated
    • Ionis Pharmaceuticals, Inc.
    • Sarepta Therapeutics, Inc.

第12章 アナリストの全方位展望

図表

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Rare Neurological Disease Treatment Market: Drug Class Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Drug Class
  • TABLE Global Rare Neurological Disease Treatment Market, by Drug Class 2018-2030 (USD Million)
  • TABLE Rare Neurological Disease Treatment Market: Disease Type Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Disease Type
  • TABLE Global Rare Neurological Disease Treatment Market, by Disease Type 2018-2030 (USD Million)
  • TABLE Rare Neurological Disease Treatment Market: Regional snapshot (2022)
  • TABLE Rare Neurological Disease Treatment Market: Application Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Application
  • TABLE Global Rare Neurological Disease Treatment Market, by Application 2018-2030 (USD Million)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Rare Neurological Disease Treatment Market, by Region 2018-2030 (USD Million)
  • TABLE North America Rare Neurological Disease Treatment Market, by Country, 2018-2030 (USD Million)
  • TABLE North America Rare Neurological Disease Treatment Market, by Drug Class, 2018-2030 (USD Million)
  • TABLE North America Rare Neurological Disease Treatment Market, by Disease Type, 2018-2030 (USD Million)
  • TABLE North America Rare Neurological Disease Treatment Market, by Application, 2018-2030 (USD Million)
  • TABLE Europe Rare Neurological Disease Treatment Market, by Country, 2018-2030 (USD Million)
  • TABLE Europe Rare Neurological Disease Treatment Market, by Drug Class, 2018-2030 (USD Million)
  • TABLE Europe Rare Neurological Disease Treatment Market, by Disease Type, 2018-2030 (USD Million)
  • TABLE Europe Rare Neurological Disease Treatment Market, by Application, 2018-2030 (USD Million)
  • TABLE Asia Pacific Rare Neurological Disease Treatment Market, by Country, 2018-2030 (USD Million)
  • TABLE Asia Pacific Rare Neurological Disease Treatment Market, by Drug Class, 2018-2030 (USD Million)
  • TABLE Asia Pacific Rare Neurological Disease Treatment Market, by Disease Type, 2018-2030 (USD Million)
  • TABLE Asia Pacific Rare Neurological Disease Treatment Market, by Application, 2018-2030 (USD Million)
  • TABLE Latin America Rare Neurological Disease Treatment Market, by Country, 2018-2030 (USD Million)
  • TABLE Latin America Rare Neurological Disease Treatment Market, by Drug Class, 2018-2030 (USD Million)
  • TABLE Latin America Rare Neurological Disease Treatment Market, by Disease Type, 2018-2030 (USD Million)
  • TABLE Latin America Rare Neurological Disease Treatment Market, by Application, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Rare Neurological Disease Treatment Market, by Country, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Rare Neurological Disease Treatment Market, by Drug Class, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Rare Neurological Disease Treatment Market, by Disease Type, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Rare Neurological Disease Treatment Market, by Application, 2018-2030 (USD Million)

List of Figures

  • FIGURE Rare Neurological Disease Treatment Market Segmentation
  • FIGURE Market research methodology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE COVID-19 Impact Analysis
  • FIGURE Pre & Post COVID-19 Impact Comparision Study
  • FIGURE Competitive Landscape; Key company market share analysis, 2022
  • FIGURE Drug Class segment market share analysis, 2022 & 2030
  • FIGURE Drug Class segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Disease Type segment market share analysis, 2022 & 2030
  • FIGURE Disease Type segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Application segment market share analysis, 2022 & 2030
  • FIGURE Application segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Regional segment market share analysis, 2022 & 2030
  • FIGURE Regional segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE North America Rare Neurological Disease Treatment Market share and leading players, 2022
  • FIGURE Europe Rare Neurological Disease Treatment Market share and leading players, 2022
  • FIGURE Asia Pacific Rare Neurological Disease Treatment Market share and leading players, 2022
  • FIGURE Latin America Rare Neurological Disease Treatment Market share and leading players, 2022
  • FIGURE Middle East and Africa Rare Neurological Disease Treatment Market share and leading players, 2022
  • FIGURE North America market share analysis by country, 2022
  • FIGURE U.S. Rare Neurological Disease Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Canada Rare Neurological Disease Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Europe Rare Neurological Disease Treatment Market share analysis by country, 2022
  • FIGURE Germany Rare Neurological Disease Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Spain Rare Neurological Disease Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Italy Rare Neurological Disease Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE France Rare Neurological Disease Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE UK Rare Neurological Disease Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Russia Rare Neurological Disease Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Netherlands Rare Neurological Disease Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Sweden Rare Neurological Disease Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Poland Rare Neurological Disease Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of the Europe Rare Neurological Disease Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Asia Pacific Rare Neurological Disease Treatment Market share analysis by country, 2022
  • FIGURE India Rare Neurological Disease Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE China Rare Neurological Disease Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Japan Rare Neurological Disease Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE South Korea Rare Neurological Disease Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Australia Rare Neurological Disease Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Thailand Rare Neurological Disease Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Indonesia Rare Neurological Disease Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Phillipines Rare Neurological Disease Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of APAC Rare Neurological Disease Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America Rare Neurological Disease Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America Rare Neurological Disease Treatment Market share analysis by country, 2022
  • FIGURE Brazil Rare Neurological Disease Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Mexico Rare Neurological Disease Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Argentina Rare Neurological Disease Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Colombia Rare Neurological Disease Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of LATAM Rare Neurological Disease Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa Rare Neurological Disease Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa Rare Neurological Disease Treatment Market share analysis by country, 2022
  • FIGURE Saudi Arabia Rare Neurological Disease Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE United Arab Emirates Rare Neurological Disease Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Israel Rare Neurological Disease Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Turkey Rare Neurological Disease Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Algeria Rare Neurological Disease Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Egypt Rare Neurological Disease Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of MEA Rare Neurological Disease Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
目次
Product Code: ANV1476

REPORT HIGHLIGHT

Rare Neurological Disease Treatment Market size was valued at USD 9,435.3 Million in 2022, expanding at a CAGR of 7.7% from 2023 to 2030.

The treatment of rare neurological diseases varies depending on the specific condition and its underlying cause. Thus, it becomes essential to consult with a healthcare professional or specialist for treatment of these neurological diseases.

Rare Neurological Disease Treatment Market- Market Dynamics:

Increasing research and development activities is expected to propel the rare neurological disease treatment demand.

Collaboration among researchers, medical professionals, pharmaceutical firms, and patient advocacy organizations has been essential in promoting the creation of medicines for uncommon neurological illnesses. Patient advocacy groups promote research, help, and create awareness, which improves patient outcomes and treatment alternatives. Technology advancements like next-generation sequencing, high-throughput screening, and gene editing methods have sped up the search for and development of viable treatments for uncommon neurological illnesses. Researchers may now identify therapeutic targets, create brand-new medications, and personalize therapy strategies thanks to these technologies.

The biological genetic and molecular developments involved in uncommon neurological illnesses are now better understood because of developments in genomics and molecular biology. This information has created new possibilities for precision medicine and targeted therapeutics.

Rare Neurological Disease Treatment Market- Key Insights:

  • As per the analysis shared by our research analyst, the global Rare Neurological Disease Treatment market is estimated to grow annually at a CAGR of around 7.7% over the forecast period (2023-2030)
  • The Rare Neurological Disease Treatment industry is projected to grow at a significant rate due to the growing focus on animal health and nutrition.
  • Based on Disease Type, Alzheimer's disease segment was predicted to show maximum market share in the year 2022.
  • Based on Application, hospital pharmacies segment is expected to hold significant market share by 2030.
  • Based on Drug Class segmentation, anti-depressants segment was the leading in 2022
  • On the basis of region, North America was the leading revenue generator in 2022.

Rare Neurological Disease Treatment Market- Segmentation Analysis:

The Global Rare Neurological Disease Treatment Market is segmented on the basis of Drug Class, Disease Type, Application, and Region.

The market is divided into five categories based on Drug Class: Anti-depressants, anti-psychotics, cholinesterase inhibitors, biologics, and others. The Anti-depressants segment dominates the market. Growing demand for anti-depressants for disease care is contributing to market growth.

The market is divided into four categories based on Disease Type: Alzheimer's disease, narcolepsy, sclerosis, and others. The Alzheimer's disease segment dominates the market. Growing prevalence of Alzheimer disorders which is influencing the market growth.

The market is divided into three categories based on Application: hospitals & clinics, surgical centers, and others. The hospitals pharmacies segment dominates the market. The rising number of neurological disease treatment at hospital level is increasing the segment growth.

Rare Neurological Disease Treatment Market- Geographical Insights:

Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business.

Rare Neurological Disease Treatment Market- Competitive Landscape:

Owing to the rising prevalence of neurological disorders, which influence the rare neurological disease treatment market. Several distribution channels, including corporate websites, and Disease Types, are used by businesses to sell their solutions & products. Products compete on various factors, such as technology, product creation, and marketing. reputation, and availability. Some of the primary techniques, and strategies used by corporations to consolidate their reach and grow their market share include new product launches, R&D expenditure, developing its distribution network and mergers & acquisitions. Some of the recent developments are mentioned below.

Recent Developments:

In 2021, Biogen developed Spinraza (nusinersen), an antisense oligonucleotide, for the treatment of small molecular therapies.

Key features of the study:

  • This proposed research study on Rare Neurological Disease Treatment market provides market size (US$ million), compound annual growth rate (CAGR %) and forecast estimation (2023-2030), considering 2022 as the base year
  • The report provides the client the latest up-to-date and trending insights about the Rare Neurological Disease Treatment market.
  • The research report elucidates potential growth opportunities across different segments/countries and explains attractive investment proposition matrix for Rare Neurological Disease Treatment market
  • The overall report identifies new investment opportunities, challenges faced by established players, and growth factors to sustain in the Rare Neurological Disease Treatment market
  • Impact of COVID-19 on Rare Neurological Disease Treatment market size, forecast, CAGR, and market dynamics are discussed in detail under the research scope. Detailed insight on Rare Neurological Disease Treatment market post-COVID will also be covered.
  • In order to give the users of this report a comprehensive view on the Rare Neurological Disease Treatment market, we have also included competitive landscape and key innovator analysis for the Rare Neurological Disease Treatment market.
  • The study encompasses a growth prospect mapping analysis, wherein all the industry segments are benchmarked based on their market size, growth rate and attractiveness.
  • The report offers detailed company profiling featuring major market participants which will help users to understand their financial in Drug Class and strategic initiatives of players operating in the Rare Neurological Disease Treatment market.
  • In addition, the report also unveil the important acquisitions & mergers, collaborations & joint ventures, new launch, research & development, regional expansion of major participants involved in the market on global as well as regional level.
  • The global Rare Neurological Disease Treatment market report primarily caters to various stakeholders in this industry including suppliers, investors, new entrants, distributors, and financial analysts

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL RARE NEUROLOGICAL DISEASE TREATMENT MARKET KEY PLAYERS

  • Biogen Inc.
  • Genzyme Corporation
  • Novartis International AG
  • Roche Holding AG
  • Pfizer Inc.
  • Johnson & Johnson
  • AbbVie Inc.
  • Merck & Co., Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Takeda Pharmaceutical Company Limited
  • Alexion Pharmaceuticals, Inc.
  • Amgen Inc.
  • Vertex Pharmaceuticals Incorporated
  • Ionis Pharmaceuticals, Inc.
  • Sarepta Therapeutics, Inc.

GLOBAL RARE NEUROLOGICAL DISEASE TREATMENT MARKET, BY DRUG CLASS

  • Anti-depressants
  • Anti-psychotics
  • Cholinesterase inhibitors
  • Biologics
  • Others

GLOBAL RARE NEUROLOGICAL DISEASE TREATMENT MARKET, BY DISEASE TYPE

  • Alzheimer's disease
  • Narcolepsy
  • Sclerosis
  • Others

GLOBAL RARE NEUROLOGICAL DISEASE TREATMENT MARKET, BY APPLICATION

  • Hospitals & clinics
  • Surgical centers
  • Others

GLOBAL RARE NEUROLOGICAL DISEASE TREATMENT MARKET, BY REGION

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Rare Neurological Disease Treatment Market Overview

  • 1.1. Study Scope

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Rare Neurological Disease Treatment Market Snippet by Drug Class
    • 2.1.2. Rare Neurological Disease Treatment Market Snippet by Disease Type
    • 2.1.3. Rare Neurological Disease Treatment Market Snippet by Application
    • 2.1.4. Rare Neurological Disease Treatment Market Snippet by Country
    • 2.1.5. Rare Neurological Disease Treatment Market Snippet by Region
  • 2.2. Competitive Insights

3. Rare Neurological Disease Treatment Key Market Trends

  • 3.1. Rare Neurological Disease Treatment Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Rare Neurological Disease Treatment Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Rare Neurological Disease Treatment Market Opportunities
  • 3.4. Rare Neurological Disease Treatment Market Future Trends

4. Rare Neurological Disease Treatment Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Rare Neurological Disease Treatment Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Rare Neurological Disease Treatment Market Landscape

  • 6.1. Rare Neurological Disease Treatment Market Share Analysis, 2022
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Rare Neurological Disease Treatment Market - By Drug Class

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Drug Class, 2022 & 2030 (%)
    • 7.1.2. Anti-depressants
    • 7.1.3. Anti-psychotics
    • 7.1.4. Cholinesterase inhibitors
    • 7.1.5. Biologics
    • 7.1.6. Others

8. Rare Neurological Disease Treatment Market - By Disease Type

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Disease Type, 2022 & 2030 (%)
    • 8.1.2. Alzheimer's disease
    • 8.1.3. Narcolepsy
    • 8.1.4. Sclerosis
    • 8.1.5. Others

9. Rare Neurological Disease Treatment Market - By Application

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Disease Type, 2022 & 2030 (%)
    • 9.1.2. Hospital & clinics
    • 9.1.3. Surgical centers
    • 9.1.4. Others

10. Rare Neurological Disease Treatment Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Rare Neurological Disease Treatment Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Rare Neurological Disease Treatment Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Rare Neurological Disease Treatment Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Rare Neurological Disease Treatment Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Rare Neurological Disease Treatment Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)

11. Key Vendor Analysis- Rare Neurological Disease Treatment Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. Biogen Inc.
    • 11.2.2. Genzyme Corporation
    • 11.2.3. Novartis International AG
    • 11.2.4. Roche Holding AG
    • 11.2.5. Pfizer Inc.
    • 11.2.6. Johnson & Johnson
    • 11.2.7. AbbVie Inc.
    • 11.2.8. Merck & Co., Inc.
    • 11.2.9. Teva Pharmaceutical Industries Ltd.
    • 11.2.10. Takeda Pharmaceutical Company Limited
    • 11.2.11. Alexion Pharmaceuticals, Inc.
    • 11.2.12. Amgen Inc.
    • 11.2.13. Vertex Pharmaceuticals Incorporated
    • 11.2.14. Ionis Pharmaceuticals, Inc.
    • 11.2.15. Sarepta Therapeutics, Inc.

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us